-+ 0.00%
-+ 0.00%
-+ 0.00%
Medirom Receives Nasdaq Delisting Notice Over Delayed Annual Report
Share
Listen to the news
Medirom Receives Nasdaq Delisting Notice Over Delayed Annual Report
  • Medirom received a Nasdaq delisting notice November 13, 2026, for failing to file its 2025 annual report within an extended deadline.
  • The overdue Form 20-F, covering the year ended December 31, 2025, was filed November 18, 2026.
  • A hearing request submitted November 18, 2026, automatically stayed suspension of trading in its American Depositary Shares for 15 days.
  • Trading suspension had been scheduled for November 24, 2026; an extended stay pending completion of the hearing process has been requested.
  • A separate minimum bid price deficiency remains unresolved, with an April 5, 2027, compliance deadline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-467253), on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending